139 related articles for article (PubMed ID: 23186951)
21. Secondary prevention of hip fractures among the hospitalized elderly: are we doing enough?
Kamel HK
J Clin Rheumatol; 2005 Apr; 11(2):68-71. PubMed ID: 16357705
[TBL] [Abstract][Full Text] [Related]
22. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.
Ferrari S; Reginster JY; Brandi ML; Kanis JA; Devogelaer JP; Kaufman JM; Féron JM; Kurth A; Rizzoli R
Arch Osteoporos; 2016 Dec; 11(1):37. PubMed ID: 27800591
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation.
Pedersen AB; Heide-Jørgensen U; Sørensen HT; Prieto-Alhambra D; Ehrenstein V
JAMA Netw Open; 2019 Apr; 2(4):e192416. PubMed ID: 31002319
[TBL] [Abstract][Full Text] [Related]
24. Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data.
Shalev V; Sharman Moser S; Goldshtein I; Yu J; Weil C; Ish-Shalom S; Rouach V; Chodick G
Ann Pharmacother; 2017 Sep; 51(9):757-767. PubMed ID: 28535690
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia.
Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC
Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349
[TBL] [Abstract][Full Text] [Related]
26. Telecarers improve osteoporosis treatment and compliance rates in secondary osteoporosis prevention for elderly hip fracture patients.
Gani LU; Tan FCL; King TFJ
Singapore Med J; 2023 Apr; 64(4):244-248. PubMed ID: 35706369
[TBL] [Abstract][Full Text] [Related]
27. Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
Nguyen ET; Posas-Mendoza T; Siu AM; Ahn HJ; Choi SY; Lim SY
Osteoporos Int; 2018 Aug; 29(8):1827-1832. PubMed ID: 29744567
[TBL] [Abstract][Full Text] [Related]
28. Value of a coordinated management of osteoporosis via Fracture Liaison Service for the treatment of orthogeriatric patients.
Schray D; Neuerburg C; Stein J; Gosch M; Schieker M; Böcker W; Kammerlander C
Eur J Trauma Emerg Surg; 2016 Oct; 42(5):559-564. PubMed ID: 27458065
[TBL] [Abstract][Full Text] [Related]
29. Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.
Prieto-Alhambra D; Judge A; Arden NK; Cooper C; Lyles KW; Javaid MK
Osteoporos Int; 2014 Jan; 25(1):77-83. PubMed ID: 23812596
[TBL] [Abstract][Full Text] [Related]
30. Osteoporosis and its complications.
Varacallo MA; Fox EJ
Med Clin North Am; 2014 Jul; 98(4):817-31, xii-xiii. PubMed ID: 24994054
[TBL] [Abstract][Full Text] [Related]
31. [Role of pharmaceutical intervention in the treatment of osteoporosis and prevention of fracture].
Nakamura T
Nihon Rinsho; 2009 May; 67(5):903-8. PubMed ID: 19432107
[TBL] [Abstract][Full Text] [Related]
32. Improving care after hip fracture: the fracture? Think osteoporosis (FTOP) program.
Dore N; Kennedy C; Fisher P; Dolovich L; Farrauto L; Papaioannou A
BMC Geriatr; 2013 Dec; 13():130. PubMed ID: 24314319
[TBL] [Abstract][Full Text] [Related]
33. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
[TBL] [Abstract][Full Text] [Related]
34. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study.
Kim SC; Kim MS; Sanfélix-Gimeno G; Song HJ; Liu J; Hurtado I; Peiró S; Lee J; Choi NK; Park BJ; Avorn J
Am J Med; 2015 May; 128(5):519-26.e1. PubMed ID: 25660252
[TBL] [Abstract][Full Text] [Related]
35. Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012.
Cheung MY; Ho AW; Wong SH
Hong Kong Med J; 2018 Dec; 24(6):579-583. PubMed ID: 30449735
[TBL] [Abstract][Full Text] [Related]
36. Management of osteoporosis in geriatric populations.
Schneider DL
Curr Osteoporos Rep; 2008 Sep; 6(3):100-7. PubMed ID: 18752771
[TBL] [Abstract][Full Text] [Related]
37. Osteoporosis treatment rate following hip fracture in a community hospital.
Khan AA; AbuAlrob H; Tariq F; Tauqir M; Zalzal P; M'Hiri I; Khan M; Ginty M; Weening B
Arch Osteoporos; 2021 Jan; 16(1):8. PubMed ID: 33409668
[TBL] [Abstract][Full Text] [Related]
38. Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.
Gonnelli S; Caffarelli C; Iolascon G; Bertoldo F; Letizia Mauro G; Patti A; Nuti R
Aging Clin Exp Res; 2017 Oct; 29(5):1031-1037. PubMed ID: 27943127
[TBL] [Abstract][Full Text] [Related]
39. Screening and treatment of osteoporosis after hip fracture: comparison of sex and race.
Antonelli M; Einstadter D; Magrey M
J Clin Densitom; 2014; 17(4):479-83. PubMed ID: 24657109
[TBL] [Abstract][Full Text] [Related]
40. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
